SCHEMBL20014229

SCHEMBL20014229

O=C(O)Cc1cnc(NC(=O)Cc2cccnc2)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 11/20 0.62
▸ CDK2 P24941 11/20 0.62
▸ CDK5 Q00535 9/20 0.62
▸ GLS O94925 5/20 0.57
▸ NAPRT Q6XQN6 1/20 0.56
▸ CDK1 P06493 3/20 0.54
▸ CDK4 P11802 3/20 0.54
▸ CCNB1 P14635 3/20 0.54
▸ CCND1 P24385 3/20 0.54
▸ CCNB2 O95067 2/20 0.54
▸ CCNE2 O96020 2/20 0.54
▸ CCNB3 Q8WWL7 2/20 0.54
▸ CCND2 P30279 1/20 0.54
▸ CCND3 P30281 1/20 0.54
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CCNT1 O60563 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ CCNA2 P20248 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5836526 0.89 CCNE1 (0.64) CCNE1CDK2CDK5GLSCDK1
SCHEMBL20014231 0.87 CCNE1 (0.58) CCNE1CDK2CDK5GLSCDK1
SCHEMBL5835963 0.84 CCNE1 (0.58) CCNE1CDK2CDK5GLSCDK1
SCHEMBL20014219 0.84 CCNE1 (0.52) CCNE1CDK2CDK5GLSCDK1
SCHEMBL27578137 0.82 CCNE1 (0.76) CCNE1CDK2CDK5GLSCDK1
SCHEMBL13694242 0.82 GLS (0.59) CCNE1CDK2CDK5GLSCDK1
SCHEMBL27549850 0.79 CCNE1 (0.77) CCNE1CDK2CDK5GLSCDK1
SCHEMBL29645003 0.79 CCNE1 (0.77) CCNE1CDK2CDK5GLSCDK1
SCHEMBL20014202 0.79 MAPT (0.56) CCNE1CDK2CDK5GLSALDH1A1
SCHEMBL6250103 0.78 CCNE1 (0.55) CCNE1CDK2CDK5GLSCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4275759-A2 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER Dana-Farber Cancer Institute, Inc. (US) 2023-11-15 — — EP disclosed
EP-3515449-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2023-07-12 — — EP disclosed
WO-2018058029-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-03-29 — — WO disclosed
Send feedback